首页|探究功能性胃肠病患者应用氯哌噻吨美利曲辛治疗的临床效果

探究功能性胃肠病患者应用氯哌噻吨美利曲辛治疗的临床效果

扫码查看
目的 探讨氟哌噻吨美利曲辛片运用于功能性胃肠病患者中的效果.方法 随机选取2020年10月—2023年10月三明市第二医院收治的100例功能性胃肠病患者为研究对象,使用随机数表法分为两组,即对照组(50例,常规治疗)和研究组(50例,在对照组基础上行氟哌噻吨美利曲辛片治疗),比较两组患者的临床疗效、消化道症状和不良反应发生情况.结果 研究组的治疗总有效率为96.00%,高于对照组的80.00%,差异有统计学意义(χ2=6.061,P<0.05).治疗后,研究组的消化道症状积分低于对照组,差异有统计学意义(P<0.05).两组不良反应总发生率比较,差异无统计学意义(P>0.05).结论 对于功能性胃肠病患者而言,选用氟哌噻吨美利曲辛片效果更好,安全性高.
Clinical Effect of Flupentixol Melitracen Table in Functional Gastrointesti-nal Disease Patients
Objective To investigate the effect of flupentixol melitracen tablets in patients with functional gastrointesti-nal disease.Methods A total of 100 patients with functional gastrointestinal disease admitted to Sanming Second Hos-pital from October 2020 to October 2023 were randomly selected as the study subjects,and were divided into two groups by using random number table method:control group(50 cases,conventional treatment)and study group(50 cases,flupentixol melitracen tablets treatment on the basis of the control group).The clinical efficacy,gastrointestinal symptoms and adverse reactions were compared between the two groups.Results The total effective rate of treatment in the study group was 96.00%,which was higher than that of the control group(80.00%),and the difference was sta-tistically significant(χ2=6.061,P<0.05).After treatment,the score of gastrointestinal symptoms in the study group was lower than that in the control group,and the difference was statistically significant(P<0.05).There was no statistically significant difference in the total incidence of adverse reactions between the two groups(P>0.05).Conclusion For pa-tients with functional gastrointestinal disease,the choice of flupentixol melitracen tablets has better effect and high safety.

Flupentixol melitracen tabletsFunctional gastrointestinal diseaseGastrointestinal symptom scoreAdverse reaction

傅天荣、陈佳蕾、刘依心

展开 >

三明市第二医院消化内科,福建三明 366000

氟哌噻吨美利曲辛片 功能性胃肠病 消化道症状积分 不良反应

2024

中外医疗
卫生部医院管理研究所 二十一世纪联合创新医药科学研究院

中外医疗

影响因子:0.909
ISSN:1674-0742
年,卷(期):2024.43(16)
  • 13